Aureka Biotechnologies raises 100 million dollars in Series B funding
August 11, 2026 | 15:33
Aureka Biotechnologies secured 100 million US dollars in Series B financing to scale biological foundation model training and enhance drug discovery infrastructure.
Mobile Version